UBS Group
ALVO icon

UBS Group’s Alvotech ALVO Stock Holding History

UBS Group’s Portfolio ALVO Stock Details ALVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.1M Buy
322,157
+186,097
+137% +$818K ﹤0.01% 5476
2025
Q4 		$698K Buy
136,060
+109,322
+409% +$691K ﹤0.01% 5860
2025
Q3 		$219K Sell
26,738
-15,865
-37% -$135K ﹤0.01% 6622
2025
Q2 		$389K Sell
42,603
-4,980
-10% -$46.8K ﹤0.01% 6220
2025
Q1 		$460K Sell
47,583
-12,451
-21% -$151K ﹤0.01% 5914
2024
Q4 		$794K Buy
60,034
+59,066
+6,102% +$727K ﹤0.01% 5486
2024
Q3 		$11.5K Buy
968
+966
+48,300% +$11.2K ﹤0.01% 7675
2024
Q2 		$24 Hold
2
– – ﹤0.01% 9294
2024
Q1 		$24 Buy
+2
New +$29 ﹤0.01% 9013
2023
Q4 		– Sell
-78
Closed -$711 – 9259
2023
Q3 		$711 Buy
+78
New +$723 ﹤0.01% 8317
2023
Q2 		– Sell
-2,283
Closed -$29.5K – 8853
2023
Q1 		$29.5K Sell
2,283
-299
-12% -$3.83K ﹤0.01% 6815
2022
Q4 		$25.8K Sell
2,582
-8,157
-76% -$57K ﹤0.01% 7392
2022
Q3 		$73K Sell
10,739
-2,907
-21% -$22.4K ﹤0.01% 5991
2022
Q2 		$112K Buy
+13,646
New +$127K ﹤0.01% 5335

Other funds holding ALVO

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LC
Littlejohn & Co Greenwich, Connecticut $106M AUM 7.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group's ALVO Position: Q1 2026 in Review

UBS Group increased its Alvotech (ALVO) stake by 137% in Q1 2026, buying an estimated $818K and bringing the position to 322,157 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #5476.

UBS Group first reported a position in ALVO in Q2 2022 and has held it in 14 quarters since. 57 funds tracked by Wall St. Rank hold ALVO as of Q1 2026.

  • UBS Group held 322,157 shares of Alvotech worth $1.1M as of Q1 2026.
  • UBS Group bought 186,097 Alvotech shares in Q1 2026, an estimated $818K.
  • Alvotech made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5476 holding.
  • UBS Group first reported a position in Alvotech in Q2 2022 and has held it in 14 quarters since.
  • 57 funds tracked by Wall St. Rank held Alvotech as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.